These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4139877)

  • 1. Red cell 2,3-diphosphoglycerate in patients with hyperthyroidism before and after treatment.
    Monti M
    Acta Med Scand; 1974 Oct; 196(4):263-6. PubMed ID: 4139877
    [No Abstract]   [Full Text] [Related]  

  • 2. Microcalorimetric measurements of heat production in human erythrocytes. II. Hyperthyroid patients before, during and after treatment.
    Monti M; Wadsö I
    Acta Med Scand; 1976; 200(4):301-8. PubMed ID: 62491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red-cell 2,3-diphosphoglycerate in patients with hyperthryoidism.
    Alvarez-Sala JL; Urbán MA; Sicilia JJ; Diaz Fdez AJ; Fdez Mendieta F; Espinós D
    Acta Endocrinol (Copenh); 1980 Apr; 93(4):424-9. PubMed ID: 7386112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment.
    Nedrebø BG; Nygård O; Ueland PM; Lien EA
    Clin Chem; 2001 Sep; 47(9):1738-41. PubMed ID: 11514424
    [No Abstract]   [Full Text] [Related]  

  • 5. T3 thyrotoxicosis. Thyrotoxicosis due to elevated serum triiodothyronine levels.
    Sterling K; Refetoff S; Selenkow HA
    JAMA; 1970 Jul; 213(4):571-5. PubMed ID: 4193903
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH; Richards AR; Addison GM; Owen GM
    Lancet; 1974 Nov; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol versus carbimazole as the sole treatment for thyrotoxicosis. A consideration of circulating thyroid hormone levels and tissue thyroid function.
    O'Malley BP; Abbott RJ; Barnett DB; Northover BJ; Rosenthal FD
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):545-52. PubMed ID: 7105427
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidism.
    Aro A; Huttunen JK; Lamberg BA; Pelkonen R; Ikkala E; Kuusisto A; Rissanen V; Salmi J; Tervonen S
    Acta Endocrinol (Copenh); 1981 Mar; 96(3):321-7. PubMed ID: 7211093
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 11. Triiodothyronine radioimmunoassay in the assessment of thyroid function.
    Sadler WA; Brownlie BE
    N Z Med J; 1975 Apr; 81(537):328-34. PubMed ID: 49868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell 2,3-diphosphoglycerate and oxygen affinity of hemoglobin in patients with thyroid disorders.
    Zaroulis CG; Kourides IA; Valeri CR
    Blood; 1978 Jul; 52(1):181-5. PubMed ID: 656626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of erythrocyte glucose-6-phosphate dehydrogenase in hyperthyroidism--effects of treatment].
    Mihara T; Shimoyama S; Morita S; Matsuoka I; Matsuura K
    Nihon Naibunpi Gakkai Zasshi; 1973 Apr; 49(4):691-7. PubMed ID: 4123824
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thyrostatic treatment and its adverse effects].
    Dokupilová A; Payer J
    Vnitr Lek; 2013 Nov; 59(11):989-95. PubMed ID: 24279443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of factors in hyperthyroidism, which determine the duration of suppressive treatment before recovery of thyroid stimulating hormone secretion.
    Fischer HR; Hackeng WH; Schopman W; Silberbusch J
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):575-85. PubMed ID: 7105429
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1977 Aug; 23(4):347-54. PubMed ID: 923523
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R
    Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Existence of thyroid hormones in erythrocytes during hyperthyroidism].
    GEORGES F; MARTIN J; BURG C
    Ann Med Nancy; 1962 Jun; 1():193-201. PubMed ID: 13897772
    [No Abstract]   [Full Text] [Related]  

  • 20. Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.
    Beckett GJ; Kellett HA; Gow SM; Hussey AJ; Hayes JD; Toft AD
    Br Med J (Clin Res Ed); 1985 Aug; 291(6493):427-31. PubMed ID: 3926229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.